|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/138 | (2006.01) |
| A61K 31/138 | (2013.01) | ||
| A61K 31/439 | (2006.01) | ||
| A61K 31/439 | (2013.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61K 31/58 | (2013.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 9/0075 | (2013.01) |
| (11) | Number of the document | 3650019 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19214674.4 |
| Date of filing the European patent application | 2015-05-27 | |
| (97) | Date of publication of the European application | 2020-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462003764 P | 2014-05-28 | US | |
| 201462004304 P | 2014-05-29 | US | |
| 201462042506 P | 2014-08-27 | US |
| (72) |
BARNES, Neil Christopher , GB
PASCOE, Steven John , US
|
| (73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
| (54) | FLUTICASONE FUROATE IN THE TREATMENT OF COPD |
| FLUTICASONE FUROATE IN THE TREATMENT OF COPD |